Glutaric Acidemia, Type I, Missed by Newborn Screening in an Infant With Dystonia Following Promethazine Administration

Authors:
  • DMDavid S. Millington
    David S. Millington
  • DKDwight D. Koeberl
    Dwight D. Koeberl
  • PLPhilip S. Lesser
    Philip S. Lesser

Abstract
We report a child initially diagnosed with promethazine-induced dystonia despite a lack of response to diphenhydramine therapy. On further evaluation, the child was diagnosed with glutaric acidemia, type I (GA-I), an autosomal recessive inborn error of metabolism caused by the deficiency of glutaryl-CoA dehydrogenase. The characteristic clinical feature of GA-I is an acute encephalopathic and neurologic crisis typically occurring during a catabolic state. Despite slow improvement, many patients do not fully recover from a neurologic crisis, and residual neurologic morbidity can be significant. Although newborn screening using tandem mass spectrometry is expected to enable presymptomatic diagnosis of GA-I, this patient was not detected by newborn screening with tandem mass spectrometry. Therefore, a high suspicion of GA-I must be maintained in the evaluation of childhood dystonia, even when newborn screening results are reportedly normal.

This publication has 9 references indexed in Scilit: